Recommendations of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) on topical therapy in ulcerative colitis

被引:4
|
作者
Ginard, Daniel [1 ]
Marin-Jimenez, Ignacio [2 ]
Barreiro-de Acosta, Manuel [3 ]
Ricart, Elena [4 ,5 ]
Domenech, Eugeni [5 ,6 ]
Gisbert, Javier P. [5 ,7 ]
Esteve, Maria [5 ,8 ]
Minguez, Miguel [9 ]
机构
[1] Hosp Univ Son Espases, Serv Aparato Digest, Palma De Mallorca, Spain
[2] Hosp Gen Univ Gregorio Maranon, Inst Invest Sanitaria Gregorio Maranon IiSGM, Serv Med Aparato Digest, Madrid, Spain
[3] Hosp Univ Santiago de Compostela, Serv Aparato Digest, Santiago De Compostela, A Coruna, Spain
[4] Hosp Clin Barcelona, Inst Invest Biomed August Pi I Sunyer IDIBAP, Serv Gastroenterol, Barcelona, Spain
[5] Ctr Invest Biomed Red Enfermedades Hepat & Digest, Madrid, Spain
[6] Hosp Badalona Germans Trias & Pujol, Serv Aparato Digest, Barcelona, Spain
[7] Univ Autonoma Madrid, Hosp Univ Princesa, Inst Invest Sanitaria Hosp La Princesa IIS IP, Serv Aparato Digest, Madrid, Spain
[8] Hosp Univ Mutua Terrassa, Serv Aparato Digest, Barcelona, Spain
[9] Univ Valencia, Hosp Clin Valencia, Serv Med Digest, Valencia, Spain
来源
GASTROENTEROLOGIA Y HEPATOLOGIA | 2020年 / 43卷 / 02期
关键词
Topical treatment; Ulcerative colitis; Mesalazine; Corticosteroids; 5-AMINOSALICYLIC ACID; DOUBLE-BLIND; CLINICAL-TRIAL; RECTAL MESALAMINE; MESALAZINE ENEMAS; EFFICACY; PROCTITIS; COMBINATION; FOAM; SUPPOSITORIES;
D O I
10.1016/j.gastrohep.2019.10.004
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Although most patients with ulcerative colitis should be given topical treatment, different studies have shown that they are underused in clinical practice. The purpose of this article is to answer 10 specific questions about which drugs are available for topical use in the treatment of ulcerative colitis, and their characteristics in terms of formulation, dosage, presentation, application and proximal distribution of rectal-administered drugs. The efficacy of available topical drugs and the benefits of combining different formulations and routes of administration, and their usefulness during disease remission are evaluated. Finally, a series of recommendations addressed to patients are given on the correct application of topical treatment. (C) 2019 The Authors. Published by Elsevier Espana, S.L.U.
引用
收藏
页码:97 / 105
页数:9
相关论文
共 50 条
  • [21] Naltrexone Therapy for Crohn's Disease and Ulcerative Colitis
    Weinstock, Leonard B.
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2014, 48 (08) : 742 - 742
  • [22] Biological therapy in Crohn's disease and ulcerative colitis
    Dolz, C.
    MEDICINA BALEAR, 2008, 23 (03): : 19 - 23
  • [23] Crohn's Disease and Ulcerative Colitis
    Dettinger, Margaret
    Matzke, Mary
    McKay, Kasi
    Sizer, Rowena
    Thoreson, Michelle
    Wrobleski, Diane
    JOURNAL OF CONTINUING EDUCATION IN NURSING, 2008, 39 (04): : 151 - 152
  • [24] Ulcerative colitis?: Crohn's disease?
    Makó, EK
    Mester, AR
    Györke, T
    Tarján, Z
    Karlinger, K
    EUROPEAN JOURNAL OF RADIOLOGY, 2000, 35 (03) : 209 - 212
  • [25] Crohn's disease and ulcerative colitis
    Burisch, Johan
    DANISH MEDICAL JOURNAL, 2014, 61 (01):
  • [26] Recommendations of the Spanish Group on Crohn's Disease and Ulcerative Colitis on the importance, screening and vaccination in inflammatory bowel disease patients
    Ferreiro-Iglesias, Rocio
    Piqueras, Marta
    Ricart, Elena
    Sempere, Laura
    Roca, Mariona
    de Carpi, Javier Martin
    Benitez, Olga
    Zabana, Yamile
    Manosa, Miriam
    Rodriguez-Moranta, Francisco
    Barreiro-de Acosta, Manuel
    GASTROENTEROLOGIA Y HEPATOLOGIA, 2022, 45 (10): : 805 - 818
  • [27] Position statement of the Spanish Society of Primary Care Physicians (SEMERGEN) and Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) on the management of inflammatory bowel disease in Primary Care
    Ginard, Daniel
    Fontanillas, Noelia
    Baston-Rey, Iria
    Pejenaute, M. Elena
    Piqueras, Marta
    Alcalde, Silvia
    Nos, Pilar
    Ricote, Mercedes
    Exposito, Lucia
    Manosa, Miriam
    Barreiro-de Acosta, Manuel
    Rodriguez-Moranta, Francisco
    Zabana, Yamile
    Polo, Jose
    Gutierrez, Ana
    GASTROENTEROLOGIA Y HEPATOLOGIA, 2025, 48 (03):
  • [28] Azathioprine therapy in Crohn's disease and ulcerative colitis.
    Nos, P
    Higon, MD
    Hoyos, M
    Ramirez, JJ
    Garcia, A
    Hinojosa, J
    Moles, JR
    Berenguer, J
    GASTROENTEROLOGY, 1997, 112 (04) : A1051 - A1051
  • [29] Is thiopurine therapy in ulcerative colitis as effective as in Crohn's disease?
    Ghosh, S
    Chaudhary, R
    Carpani, M
    Playford, RJ
    GUT, 2006, 55 (01) : 6 - 8
  • [30] Advances in biologic therapy for ulcerative colitis and Crohn's disease
    D'Haens G.
    Daperno M.
    Current Gastroenterology Reports, 2006, 8 (6) : 506 - 512